feed,title,long_url,short_url
Benzinga,AzurRx's Stock Falls After MS1819 For Pancreatic Insufficiency Flunks Mid-Stage Study,https://benzinga.com/general/biotech/21/04/20441495/azurrxs-stock-falls-after-ms1819-for-pancreatic-insufficiency-flunks-mid-stage-study,https://j.mp/3dkNeI6
